0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Long-acting Glucocorticoid Injection Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-32Z17035
Home | Market Reports
Global Long acting Glucocorticoid Injection Market Research Report 2024
BUY CHAPTERS

Global Long-acting Glucocorticoid Injection Market Research Report 2026

Code: QYRE-Auto-32Z17035
Report
2026-04-10
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Long-acting Glucocorticoid Injection Market

The global Long-acting Glucocorticoid Injection market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Long-acting Glucocorticoid Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Long-acting glucocorticoid injection is a drug with anti-inflammatory, anti-rheumatic and immunosuppressive effects, and is often used to treat allergic and autoimmune inflammatory diseases.
The North American market for Long-acting Glucocorticoid Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Long-acting Glucocorticoid Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Long-acting Glucocorticoid Injection include Eurocrit Labs, Pyxus Pharmaceutical, SiNi Pharma, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Wellona Pharma, Caspian Tamin Pharmaceutical Company, AdvaCare Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Long-acting Glucocorticoid Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Long-acting Glucocorticoid Injection. The Long-acting Glucocorticoid Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Long-acting Glucocorticoid Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Long-acting Glucocorticoid Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Long-acting Glucocorticoid Injection Market Report

Report Metric Details
Report Name Long-acting Glucocorticoid Injection Market
Segment by Type
  • Dexamethasone Hormone Injection
  • Betamethasone Hormone Injection
by Application
  • Rheumatoid Arthritis
  • Allergic Diseases
  • Bronchial Asthma
  • Autoimmune Disease
  • Skin Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Eurocrit Labs, Pyxus Pharmaceutical, SiNi Pharma, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Wellona Pharma, Caspian Tamin Pharmaceutical Company, AdvaCare Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Long-acting Glucocorticoid Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Long-acting Glucocorticoid Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Long-acting Glucocorticoid Injection Market report?

Ans: The main players in the Long-acting Glucocorticoid Injection Market are Eurocrit Labs, Pyxus Pharmaceutical, SiNi Pharma, Zydus Cadila, Weefsel Pharma, Taj Pharmaceuticals Limited, Wellona Pharma, Caspian Tamin Pharmaceutical Company, AdvaCare Pharma

What are the Application segmentation covered in the Long-acting Glucocorticoid Injection Market report?

Ans: The Applications covered in the Long-acting Glucocorticoid Injection Market report are Rheumatoid Arthritis, Allergic Diseases, Bronchial Asthma, Autoimmune Disease, Skin Diseases, Others

What are the Type segmentation covered in the Long-acting Glucocorticoid Injection Market report?

Ans: The Types covered in the Long-acting Glucocorticoid Injection Market report are Dexamethasone Hormone Injection, Betamethasone Hormone Injection

1 Long-acting Glucocorticoid Injection Market Overview
1.1 Product Definition
1.2 Long-acting Glucocorticoid Injection by Type
1.2.1 Global Long-acting Glucocorticoid Injection Market Value by Type: 2025 vs 2032
1.2.2 Dexamethasone Hormone Injection
1.2.3 Betamethasone Hormone Injection
1.3 Long-acting Glucocorticoid Injection by Application
1.3.1 Global Long-acting Glucocorticoid Injection Market Value by Application: 2025 vs 2032
1.3.2 Rheumatoid Arthritis
1.3.3 Allergic Diseases
1.3.4 Bronchial Asthma
1.3.5 Autoimmune Disease
1.3.6 Skin Diseases
1.3.7 Others
1.4 Global Long-acting Glucocorticoid Injection Market Size Estimates and Forecasts
1.4.1 Global Long-acting Glucocorticoid Injection Revenue 2021–2032
1.4.2 Global Long-acting Glucocorticoid Injection Sales 2021–2032
1.4.3 Global Long-acting Glucocorticoid Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Long-acting Glucocorticoid Injection Market Competition by Manufacturers
2.1 Global Long-acting Glucocorticoid Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Long-acting Glucocorticoid Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Long-acting Glucocorticoid Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Long-acting Glucocorticoid Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Long-acting Glucocorticoid Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Long-acting Glucocorticoid Injection, Product Types and Applications
2.7 Global Key Manufacturers of Long-acting Glucocorticoid Injection, Date of Entry into the Industry
2.8 Global Long-acting Glucocorticoid Injection Market Competitive Situation and Trends
2.8.1 Global Long-acting Glucocorticoid Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Long-acting Glucocorticoid Injection Players Market Share by Revenue
2.8.3 Global Long-acting Glucocorticoid Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Long-acting Glucocorticoid Injection Market Scenario by Region
3.1 Global Long-acting Glucocorticoid Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Long-acting Glucocorticoid Injection Sales by Region: 2021–2032
3.2.1 Global Long-acting Glucocorticoid Injection Sales by Region: 2021–2026
3.2.2 Global Long-acting Glucocorticoid Injection Sales by Region: 2027–2032
3.3 Global Long-acting Glucocorticoid Injection Revenue by Region: 2021–2032
3.3.1 Global Long-acting Glucocorticoid Injection Revenue by Region: 2021–2026
3.3.2 Global Long-acting Glucocorticoid Injection Revenue by Region: 2027–2032
3.4 North America Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.4.1 North America Long-acting Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Long-acting Glucocorticoid Injection Sales by Country (2021–2032)
3.4.3 North America Long-acting Glucocorticoid Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.5.1 Europe Long-acting Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Long-acting Glucocorticoid Injection Sales by Country (2021–2032)
3.5.3 Europe Long-acting Glucocorticoid Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Long-acting Glucocorticoid Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Long-acting Glucocorticoid Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Long-acting Glucocorticoid Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.7.1 Latin America Long-acting Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Long-acting Glucocorticoid Injection Sales by Country (2021–2032)
3.7.3 Latin America Long-acting Glucocorticoid Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Long-acting Glucocorticoid Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Long-acting Glucocorticoid Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Long-acting Glucocorticoid Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Long-acting Glucocorticoid Injection Sales by Type (2021–2032)
4.1.1 Global Long-acting Glucocorticoid Injection Sales by Type (2021–2026)
4.1.2 Global Long-acting Glucocorticoid Injection Sales by Type (2027–2032)
4.1.3 Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2021–2032)
4.2 Global Long-acting Glucocorticoid Injection Revenue by Type (2021–2032)
4.2.1 Global Long-acting Glucocorticoid Injection Revenue by Type (2021–2026)
4.2.2 Global Long-acting Glucocorticoid Injection Revenue by Type (2027–2032)
4.2.3 Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2021–2032)
4.3 Global Long-acting Glucocorticoid Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Long-acting Glucocorticoid Injection Sales by Application (2021–2032)
5.1.1 Global Long-acting Glucocorticoid Injection Sales by Application (2021–2026)
5.1.2 Global Long-acting Glucocorticoid Injection Sales by Application (2027–2032)
5.1.3 Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2021–2032)
5.2 Global Long-acting Glucocorticoid Injection Revenue by Application (2021–2032)
5.2.1 Global Long-acting Glucocorticoid Injection Revenue by Application (2021–2026)
5.2.2 Global Long-acting Glucocorticoid Injection Revenue by Application (2027–2032)
5.2.3 Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2021–2032)
5.3 Global Long-acting Glucocorticoid Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Eurocrit Labs
6.1.1 Eurocrit Labs Company Information
6.1.2 Eurocrit Labs Description and Business Overview
6.1.3 Eurocrit Labs Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Eurocrit Labs Long-acting Glucocorticoid Injection Product Portfolio
6.1.5 Eurocrit Labs Recent Developments/Updates
6.2 Pyxus Pharmaceutical
6.2.1 Pyxus Pharmaceutical Company Information
6.2.2 Pyxus Pharmaceutical Description and Business Overview
6.2.3 Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Product Portfolio
6.2.5 Pyxus Pharmaceutical Recent Developments/Updates
6.3 SiNi Pharma
6.3.1 SiNi Pharma Company Information
6.3.2 SiNi Pharma Description and Business Overview
6.3.3 SiNi Pharma Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 SiNi Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.3.5 SiNi Pharma Recent Developments/Updates
6.4 Zydus Cadila
6.4.1 Zydus Cadila Company Information
6.4.2 Zydus Cadila Description and Business Overview
6.4.3 Zydus Cadila Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Zydus Cadila Long-acting Glucocorticoid Injection Product Portfolio
6.4.5 Zydus Cadila Recent Developments/Updates
6.5 Weefsel Pharma
6.5.1 Weefsel Pharma Company Information
6.5.2 Weefsel Pharma Description and Business Overview
6.5.3 Weefsel Pharma Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Weefsel Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.5.5 Weefsel Pharma Recent Developments/Updates
6.6 Taj Pharmaceuticals Limited
6.6.1 Taj Pharmaceuticals Limited Company Information
6.6.2 Taj Pharmaceuticals Limited Description and Business Overview
6.6.3 Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Product Portfolio
6.6.5 Taj Pharmaceuticals Limited Recent Developments/Updates
6.7 Wellona Pharma
6.7.1 Wellona Pharma Company Information
6.7.2 Wellona Pharma Description and Business Overview
6.7.3 Wellona Pharma Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Wellona Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.7.5 Wellona Pharma Recent Developments/Updates
6.8 Caspian Tamin Pharmaceutical Company
6.8.1 Caspian Tamin Pharmaceutical Company Company Information
6.8.2 Caspian Tamin Pharmaceutical Company Description and Business Overview
6.8.3 Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Product Portfolio
6.8.5 Caspian Tamin Pharmaceutical Company Recent Developments/Updates
6.9 AdvaCare Pharma
6.9.1 AdvaCare Pharma Company Information
6.9.2 AdvaCare Pharma Description and Business Overview
6.9.3 AdvaCare Pharma Long-acting Glucocorticoid Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 AdvaCare Pharma Long-acting Glucocorticoid Injection Product Portfolio
6.9.5 AdvaCare Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Long-acting Glucocorticoid Injection Industry Chain Analysis
7.2 Long-acting Glucocorticoid Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Long-acting Glucocorticoid Injection Production Mode & Process Analysis
7.4 Long-acting Glucocorticoid Injection Sales and Marketing
7.4.1 Long-acting Glucocorticoid Injection Sales Channels
7.4.2 Long-acting Glucocorticoid Injection Distributors
7.5 Long-acting Glucocorticoid Injection Customer Analysis
8 Long-acting Glucocorticoid Injection Market Dynamics
8.1 Long-acting Glucocorticoid Injection Industry Trends
8.2 Long-acting Glucocorticoid Injection Market Drivers
8.3 Long-acting Glucocorticoid Injection Market Challenges
8.4 Long-acting Glucocorticoid Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Long-acting Glucocorticoid Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Long-acting Glucocorticoid Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Long-acting Glucocorticoid Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Long-acting Glucocorticoid Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Long-acting Glucocorticoid Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Long-acting Glucocorticoid Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Long-acting Glucocorticoid Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Long-acting Glucocorticoid Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Long-acting Glucocorticoid Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Long-acting Glucocorticoid Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of Long-acting Glucocorticoid Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Long-acting Glucocorticoid Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Long-acting Glucocorticoid Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Long-acting Glucocorticoid Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Long-acting Glucocorticoid Injection Sales by Region (K Units), 2021–2026
 Table 18. Global Long-acting Glucocorticoid Injection Sales Market Share by Region (2021–2026)
 Table 19. Global Long-acting Glucocorticoid Injection Sales by Region (K Units), 2027–2032
 Table 20. Global Long-acting Glucocorticoid Injection Sales Market Share by Region (2027–2032)
 Table 21. Global Long-acting Glucocorticoid Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Long-acting Glucocorticoid Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global Long-acting Glucocorticoid Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Long-acting Glucocorticoid Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America Long-acting Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Long-acting Glucocorticoid Injection Sales by Country (K Units), 2021–2026
 Table 27. North America Long-acting Glucocorticoid Injection Sales by Country (K Units), 2027–2032
 Table 28. North America Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Long-acting Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Long-acting Glucocorticoid Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe Long-acting Glucocorticoid Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Long-acting Glucocorticoid Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Long-acting Glucocorticoid Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Long-acting Glucocorticoid Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Long-acting Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Long-acting Glucocorticoid Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America Long-acting Glucocorticoid Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Long-acting Glucocorticoid Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Long-acting Glucocorticoid Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Long-acting Glucocorticoid Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Long-acting Glucocorticoid Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global Long-acting Glucocorticoid Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2021–2026)
 Table 53. Global Long-acting Glucocorticoid Injection Sales Market Share by Type (2027–2032)
 Table 54. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global Long-acting Glucocorticoid Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Long-acting Glucocorticoid Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global Long-acting Glucocorticoid Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2021–2026)
 Table 63. Global Long-acting Glucocorticoid Injection Sales Market Share by Application (2027–2032)
 Table 64. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Long-acting Glucocorticoid Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global Long-acting Glucocorticoid Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Eurocrit Labs Company Information
 Table 71. Eurocrit Labs Description and Business Overview
 Table 72. Eurocrit Labs Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Eurocrit Labs Long-acting Glucocorticoid Injection Product
 Table 74. Eurocrit Labs Recent Developments/Updates
 Table 75. Pyxus Pharmaceutical Company Information
 Table 76. Pyxus Pharmaceutical Description and Business Overview
 Table 77. Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Pyxus Pharmaceutical Long-acting Glucocorticoid Injection Product
 Table 79. Pyxus Pharmaceutical Recent Developments/Updates
 Table 80. SiNi Pharma Company Information
 Table 81. SiNi Pharma Description and Business Overview
 Table 82. SiNi Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. SiNi Pharma Long-acting Glucocorticoid Injection Product
 Table 84. SiNi Pharma Recent Developments/Updates
 Table 85. Zydus Cadila Company Information
 Table 86. Zydus Cadila Description and Business Overview
 Table 87. Zydus Cadila Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Zydus Cadila Long-acting Glucocorticoid Injection Product
 Table 89. Zydus Cadila Recent Developments/Updates
 Table 90. Weefsel Pharma Company Information
 Table 91. Weefsel Pharma Description and Business Overview
 Table 92. Weefsel Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Weefsel Pharma Long-acting Glucocorticoid Injection Product
 Table 94. Weefsel Pharma Recent Developments/Updates
 Table 95. Taj Pharmaceuticals Limited Company Information
 Table 96. Taj Pharmaceuticals Limited Description and Business Overview
 Table 97. Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Taj Pharmaceuticals Limited Long-acting Glucocorticoid Injection Product
 Table 99. Taj Pharmaceuticals Limited Recent Developments/Updates
 Table 100. Wellona Pharma Company Information
 Table 101. Wellona Pharma Description and Business Overview
 Table 102. Wellona Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Wellona Pharma Long-acting Glucocorticoid Injection Product
 Table 104. Wellona Pharma Recent Developments/Updates
 Table 105. Caspian Tamin Pharmaceutical Company Company Information
 Table 106. Caspian Tamin Pharmaceutical Company Description and Business Overview
 Table 107. Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Caspian Tamin Pharmaceutical Company Long-acting Glucocorticoid Injection Product
 Table 109. Caspian Tamin Pharmaceutical Company Recent Developments/Updates
 Table 110. AdvaCare Pharma Company Information
 Table 111. AdvaCare Pharma Description and Business Overview
 Table 112. AdvaCare Pharma Long-acting Glucocorticoid Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. AdvaCare Pharma Long-acting Glucocorticoid Injection Product
 Table 114. AdvaCare Pharma Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Long-acting Glucocorticoid Injection Distributors List
 Table 118. Long-acting Glucocorticoid Injection Customers List
 Table 119. Long-acting Glucocorticoid Injection Market Trends
 Table 120. Long-acting Glucocorticoid Injection Market Drivers
 Table 121. Long-acting Glucocorticoid Injection Market Challenges
 Table 122. Long-acting Glucocorticoid Injection Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Long-acting Glucocorticoid Injection
 Figure 2. Global Long-acting Glucocorticoid Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Long-acting Glucocorticoid Injection Market Share by Type: 2025 & 2032
 Figure 4. Dexamethasone Hormone Injection Product Picture
 Figure 5. Betamethasone Hormone Injection Product Picture
 Figure 6. Global Long-acting Glucocorticoid Injection Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Long-acting Glucocorticoid Injection Market Share by Application: 2025 & 2032
 Figure 8. Rheumatoid Arthritis
 Figure 9. Allergic Diseases
 Figure 10. Bronchial Asthma
 Figure 11. Autoimmune Disease
 Figure 12. Skin Diseases
 Figure 13. Others
 Figure 14. Global Long-acting Glucocorticoid Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Long-acting Glucocorticoid Injection Market Size (US$ Million), 2021–2032
 Figure 16. Global Long-acting Glucocorticoid Injection Sales (K Units), 2021–2032
 Figure 17. Global Long-acting Glucocorticoid Injection Average Price (US$/Unit), 2021–2032
 Figure 18. Long-acting Glucocorticoid Injection Report Years Considered
 Figure 19. Long-acting Glucocorticoid Injection Sales Share by Manufacturers in 2025
 Figure 20. Global Long-acting Glucocorticoid Injection Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Long-acting Glucocorticoid Injection Players: Market Share by Revenue in Long-acting Glucocorticoid Injection in 2025
 Figure 22. Long-acting Glucocorticoid Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Long-acting Glucocorticoid Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Long-acting Glucocorticoid Injection Sales Market Share by Country (2021–2032)
 Figure 25. North America Long-acting Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
 Figure 26. United States Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Long-acting Glucocorticoid Injection Sales Market Share by Country (2021–2032)
 Figure 29. Europe Long-acting Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Long-acting Glucocorticoid Injection Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Long-acting Glucocorticoid Injection Revenue Market Share by Region (2021–2032)
 Figure 37. China Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Long-acting Glucocorticoid Injection Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Long-acting Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Colombia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Long-acting Glucocorticoid Injection Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Long-acting Glucocorticoid Injection Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Long-acting Glucocorticoid Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Long-acting Glucocorticoid Injection by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Long-acting Glucocorticoid Injection by Type (2021–2032)
 Figure 57. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Long-acting Glucocorticoid Injection by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Long-acting Glucocorticoid Injection by Application (2021–2032)
 Figure 60. Global Long-acting Glucocorticoid Injection Price (US$/Unit) by Application (2021–2032)
 Figure 61. Long-acting Glucocorticoid Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India